{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:11:49Z","timestamp":1771546309984,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008750","name":"Shanghai Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC22026222"],"award-info":[{"award-number":["SHDC22026222"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","award":["EKSJD202419"],"award-info":[{"award-number":["EKSJD202419"]}],"id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","award":["yg2025-general-14"],"award-info":[{"award-number":["yg2025-general-14"]}],"id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.prp.2026.156399","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:24:15Z","timestamp":1770683055000},"page":"156399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pediatric NTRK-rearranged gliomas: A clinicopathological and molecular analysis of six cases"],"prefix":"10.1016","volume":"280","author":[{"given":"Jing","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongli","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.prp.2026.156399_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"Suppl 5","key":"10.1016\/j.prp.2026.156399_bib2","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012\u20132016","volume":"21","author":"Ostrom","year":"2019","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156399_bib3","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s40478-024-01798-9","article-title":"NTRK-fused central nervous system tumours: clinicopathological and genetic insights and response to TRK inhibitors","volume":"12","author":"Kim","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"issue":"7697","key":"10.1016\/j.prp.2026.156399_bib4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.prp.2026.156399_bib5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(19)30691-6","article-title":"Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials","volume":"21","author":"Doebele","year":"2020","journal-title":"Lancet Oncol."},{"issue":"12","key":"10.1016\/j.prp.2026.156399_bib6","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1097\/01.JTO.0000473485.38553.f0","article-title":"Durable clinical response to entrectinib in NTRK1-rearranged non-small cell lung cancer","volume":"10","author":"Farago","year":"2015","journal-title":"J. Thorac Oncol."},{"issue":"4","key":"10.1016\/j.prp.2026.156399_bib7","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00401-019-01987-0","article-title":"cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAF(V600E) mutation","volume":"137","author":"Ellison","year":"2019","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.prp.2026.156399_bib8","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/ng.2611","article-title":"Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas","volume":"45","author":"Zhang","year":"2013","journal-title":"Nat. Genet"},{"issue":"1","key":"10.1016\/j.prp.2026.156399_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28028","article-title":"Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors","volume":"67","author":"Lake","year":"2020","journal-title":"Pediatr. Blood Cancer"},{"issue":"3","key":"10.1016\/j.prp.2026.156399_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.32074\/1591-951X-787","article-title":"NTRK gene fusions in solid tumors: agnostic relevance, prevalence and diagnostic strategies","volume":"114","author":"Marchetti","year":"2022","journal-title":"Pathologica"},{"issue":"4","key":"10.1016\/j.prp.2026.156399_bib11","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1158\/1535-7163.MCT-15-0758","article-title":"Entrectinib, a Pan-TRK, ROS1, and ALK inhibitor with activity in multiple molecularly defined cancer indications","volume":"15","author":"Ardini","year":"2016","journal-title":"Mol. Cancer Ther."},{"issue":"4","key":"10.1016\/j.prp.2026.156399_bib12","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/2159-8290.CD-16-1237","article-title":"Safety and antitumor activity of the multitargeted Pan-TRK, ROS1, and ALK inhibitor entrectinib: combined results from two phase I trials (ALKA-372-001 and STARTRK-1)","volume":"7","author":"Drilon","year":"2017","journal-title":"Cancer Discov."},{"issue":"8","key":"10.1016\/j.prp.2026.156399_bib13","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1714448","article-title":"Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children","volume":"378","author":"Drilon","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.prp.2026.156399_bib14","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s12022-020-09648-9","article-title":"Detection of NTRK1\/3 rearrangements in papillary thyroid carcinoma using immunohistochemistry, fluorescent in situ hybridization, and next-generation sequencing","volume":"31","author":"Lee","year":"2020","journal-title":"Endocr. Pathol."},{"issue":"13","key":"10.1016\/j.prp.2026.156399_bib15","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1158\/0008-5472.CAN-19-0372","article-title":"Detection of NTRK fusions: merits and limitations of current diagnostic platforms","volume":"79","author":"Solomon","year":"2019","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.prp.2026.156399_bib16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/PAS.0000000000002202","article-title":"Primary-rearranged spindle cell neoplasm of the gastrointestinal tract: a clinicopathological and molecular analysis of 8 cases","volume":"48","author":"Gao","year":"2024","journal-title":"Am. J. Surg. Pathol."},{"issue":"Suppl_8","key":"10.1016\/j.prp.2026.156399_bib17","doi-asserted-by":"crossref","first-page":"sviii5","DOI":"10.1093\/annonc\/mdz383","article-title":"Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer","volume":"30","author":"Amatu","year":"2019","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2026.156399_bib18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000484742","article-title":"Mapping of the tyrosine kinase receptors trkA (NTRK1), trkB (NTRK2) and trkC(NTRK3) to human chromosomes 1q22, 9q22 and 15q25 by fluorescence in situ hybridization","volume":"5","author":"Valent","year":"1997","journal-title":"Eur. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.prp.2026.156399_bib19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s40478-020-00980-z","article-title":"Molecular and clinicopathologic features of gliomas harboring NTRK fusions","volume":"8","author":"Torre","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.prp.2026.156399_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00401-025-02934-y","article-title":"Pineal region high-grade neuroepithelial tumors with NTRK fusions map to the novel methylation class \"diffuse high-grade glioma, IDH-wild type, subtype E\"","volume":"150","author":"Costa","year":"2025","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.prp.2026.156399_bib21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3171\/jns.2006.105.3.461","article-title":"Oligodendroglioma of the pineal region. Case report","volume":"105","author":"Das","year":"2006","journal-title":"J. Neurosurg."},{"issue":"8","key":"10.1016\/j.prp.2026.156399_bib22","article-title":"Pineal gland tumor but not pinealoma: a case report","volume":"9","author":"Naqvi","year":"2017","journal-title":"Cureus"},{"issue":"15","key":"10.1016\/j.prp.2026.156399_bib23","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1158\/1078-0432.CCR-24-1256","article-title":"The spectrum of IDH- and H3-wildtype high-grade glioma subgroups occurring across teenage and young adult patient populations","volume":"31","author":"Pereira","year":"2025","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.prp.2026.156399_bib24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5414\/NP301455","article-title":"A case report of a novel NTRK gene fusion in pleomorphic xanthoastrocytoma","volume":"41","author":"Ahmed","year":"2022","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.prp.2026.156399_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2024.1378608","article-title":"Pleomorphic xanthoastrocytoma with NTRK fusion presenting as spontaneous intracranial hemorrhage-case report and literature review","volume":"12","author":"Wu","year":"2024","journal-title":"Front. Pediatr."},{"issue":"1","key":"10.1016\/j.prp.2026.156399_bib26","article-title":"Pleomorphic xanthoastrocytoma with anaplasia and BEND5-NTRK2 fusion in a young adult with a history of cranial radiation for childhood rhabdomyosarcoma","volume":"7","author":"Fischer","year":"2025","journal-title":"Neurooncol. Adv."},{"issue":"7","key":"10.1016\/j.prp.2026.156399_bib27","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/PAS.0000000000001062","article-title":"Pan-Trk immunohistochemistry identifies NTRK rearrangements in pediatric mesenchymal tumors","volume":"42","author":"Rudzinski","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2026.156399_bib28","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/his.13666","article-title":"Evaluation of pan-TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics","volume":"73","author":"Hung","year":"2018","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.prp.2026.156399_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pathol.2021.05.100","article-title":"Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing","volume":"54","author":"Bourhis","year":"2022","journal-title":"Pathology"},{"issue":"1","key":"10.1016\/j.prp.2026.156399_bib30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41379-018-0118-3","article-title":"Molecular characterization of cancers with NTRK gene fusions","volume":"32","author":"Gatalica","year":"2019","journal-title":"Mod. Pathol."},{"issue":"11","key":"10.1016\/j.prp.2026.156399_bib31","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1097\/PAS.0000000000000911","article-title":"Pan-Trk immunohistochemistry is an efficient and reliable screen for the detection of NTRK fusions","volume":"41","author":"Hechtman","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2026.156399_bib32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41379-019-0324-7","article-title":"NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls","volume":"33","author":"Solomon","year":"2020","journal-title":"Mod. Pathol."},{"issue":"12","key":"10.1016\/j.prp.2026.156399_bib33","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","article-title":"NTRK fusion-positive cancers and TRK inhibitor therapy","volume":"15","author":"Cocco","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2026.156399_bib34","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41416-018-0251-2","article-title":"Brief report: potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma","volume":"119","author":"Ziegler","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.prp.2026.156399_bib35","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1158\/1078-0432.CCR-24-0581","article-title":"Clinical characteristics and outcomes of central nervous system tumors harboring NTRK gene fusions","volume":"31","author":"Lamoureux","year":"2025","journal-title":"Clin. Cancer Res."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826000506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826000506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T23:41:52Z","timestamp":1771544512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826000506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":35,"alternative-id":["S0344033826000506"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156399","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric NTRK-rearranged gliomas: A clinicopathological and molecular analysis of six cases","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156399"}}